Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Sproule

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Psychopharmacology|October 23, 2019
Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adultsJustin Matheson, Beth Sproule, Patricia Di Ciano, et al.
CMAJ Open|December 9, 2014
Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysisTara Gomes, David Juurlink, Zhan Yao, et al.
Plos Medicine|April 9, 2026
Association between early methadone dose titration and treatment discontinuation and opioid toxicity: A retrospective cohort studyRia Garg, Jin Luo, Nikki Bozinoff, et al.
Addiction (Abingdon, England)|March 8, 2022
Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort studyTara Gomes, Daniel McCormack, Nikki Bozinoff, et al.
PLOS Mental Health|February 9, 2026
Patient and Prescriber characteristics associated with return to daily-dispense methadone: A multilevel cohort studyRia Garg, Shaleesa Ledlie, Daniel McCormack, et al.
Pain|July 30, 2021
Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, CanadaDiana Martins, Wayne Khuu, Mina Tadrous, et al.
The International Journal on Drug Policy|July 10, 2023
Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: A population-based time series analysisShaleesa Ledlie, Mina Tadrous, Daniel McCormack, et al.
Therapeutic Drug Monitoring|April 8, 2009
Clozapine exposure and the impact of smoking and gender: a population pharmacokinetic studyWenzie Ng, Hiroyuki Uchida, Zahinoor Ismail, et al.
Drug and Alcohol Dependence|December 3, 2023
Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: A population-based cohort study in Ontario, CanadaAnita Iacono, Tianru Wang, Mina Tadrous, et al.
Pharmacology, Biochemistry, and Behavior|May 4, 2020
Acute and residual mood and cognitive performance of young adults following smoked cannabisJustin Matheson, Robert E Mann, Beth Sproule, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Psychopharmacology|October 23, 2019
Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adultsJustin Matheson, Beth Sproule, Patricia Di Ciano, et al.
CMAJ Open|December 9, 2014
Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysisTara Gomes, David Juurlink, Zhan Yao, et al.
Plos Medicine|April 9, 2026
Association between early methadone dose titration and treatment discontinuation and opioid toxicity: A retrospective cohort studyRia Garg, Jin Luo, Nikki Bozinoff, et al.
Addiction (Abingdon, England)|March 8, 2022
Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort studyTara Gomes, Daniel McCormack, Nikki Bozinoff, et al.
PLOS Mental Health|February 9, 2026
Patient and Prescriber characteristics associated with return to daily-dispense methadone: A multilevel cohort studyRia Garg, Shaleesa Ledlie, Daniel McCormack, et al.
Pain|July 30, 2021
Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, CanadaDiana Martins, Wayne Khuu, Mina Tadrous, et al.
The International Journal on Drug Policy|July 10, 2023
Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: A population-based time series analysisShaleesa Ledlie, Mina Tadrous, Daniel McCormack, et al.
Therapeutic Drug Monitoring|April 8, 2009
Clozapine exposure and the impact of smoking and gender: a population pharmacokinetic studyWenzie Ng, Hiroyuki Uchida, Zahinoor Ismail, et al.
Drug and Alcohol Dependence|December 3, 2023
Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: A population-based cohort study in Ontario, CanadaAnita Iacono, Tianru Wang, Mina Tadrous, et al.
Pharmacology, Biochemistry, and Behavior|May 4, 2020
Acute and residual mood and cognitive performance of young adults following smoked cannabisJustin Matheson, Robert E Mann, Beth Sproule, et al.
Pageof 4